Findings

What do systematic reviews say?

4,667 questions · 21,760 findings · 2,177 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,173 · 19.2%GRADE not reported 2,300 · 10.6%Very low 5,276 · 24.2%Low 5,764 · 26.5%Moderate 3,298 · 15.2%High 949 · 4.4%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

NPWT combined with internet‐plus home care vs usual care

Adverse events Â · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPWT vs standard dressing

Time to complete healing · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPWT vs standard dressing

Adverse events · adults with pressure ulcers

It is very uncertain whether NPWT changes adverse events compared with standard dressings therapy (very low certainty).

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
RR 1.25 [0.64, 2.44]
1 study · 12 participants
Very low

NPWT vs moist wound healing

Time to complete healing · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPWT vs moist wound healing

Adverse events Â · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPWT vs the Healthpoint system

Outcomes Â · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPWT vs the Healthpoint system

Time to complete healing · adults with pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Gestational diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

It is very uncertain whether the intervention changes gestational diabetes mellitus (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 0.53 [0.31, 0.9]
6 studies · 1140 participants
Very low

Intervention not reported

Composite of serious neonatal outcomes · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Neonatal hypoglycaemia · infants of pregnant women

It is very uncertain whether the intervention changes neonatal hypoglycaemia (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 3.07 [0.9, 10.52]
4 studies · 671 participants
Very low

Intervention not reported

Adiposity · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Diabetes · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Neurosensory disability · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Caesarean section · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

The intervention showed no clear difference in caesarean section (low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 0.91 [0.77, 1.07]
4 studies · 829 participants
Low

Intervention not reported

Perineal trauma · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

It is very uncertain whether the intervention changes perineal trauma (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 4 [0.45, 35.25]
1 study · 234 participants
Very low

Intervention not reported

Development of subsequent type 2 diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Large‐for‐gestational age · infants of pregnant women

The intervention showed no clear difference in large‐for‐gestational age (low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 1.4 [0.65, 3.02]
1 study · 234 participants
Low

Intervention not reported

Perinatal mortality (stillbirth and neonatal mortality) · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Summary of findings table ‐ Rifaximin vs placebo or no intervention

Mortality ‐ total number · prevention and treatment of hepatic encephalopathy in people with cirrhosis

Summary of findings table ‐ Rifaximin showed no clear difference in mortality ‐ total number compared with placebo/no intervention (moderate certainty).

1 finding from 1 review

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2023 · Cochrane Headline outcomes only
RR 0.83 [0.5, 1.38]
13 studies · 1007 participants
Moderate

Summary of findings table ‐ Rifaximin vs non‐absorbable disaccharide

Health‐related quality of life ‐ all trials Higher scores indicate improved health‐related quality of life · prevention and treatment of hepatic encephalopathy in people with cirrhosis

1 finding from 1 review

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 249 participants
Very low